Suppr超能文献

通过湿搅拌介质研磨连续生产药物纳米颗粒悬浮液:重新审视雷宾德效应。

Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.

机构信息

Otto H. York Department of Chemical, Biological, and Pharmaceutical Engineering, New Jersey Institute of Technology, Newark, New Jersey, USA.

出版信息

Drug Dev Ind Pharm. 2013 Feb;39(2):266-83. doi: 10.3109/03639045.2012.676048. Epub 2012 Apr 16.

Abstract

Nanoparticles of BCS Class II drugs are produced in wet stirred media mills operating in batch or recirculation mode with the goal of resolving the poor water-solubility issue. Scant information is available regarding the continuous production of drug nanoparticles via wet media milling. Griseofulvin and Naproxen were milled in both recirculation mode and multi-pass continuous mode to study the breakage dynamics and to determine the effects of suspension flow rate. The evolution of the median particle size was measured and described by an empirical breakage model. We found that these two operation modes could produce drug nanosuspensions with similar particle size distributions (PSDs). A reduced suspension flow rate slowed the breakage rate and led to a wider PSD and more differentiation between the two operation modes. The latter part of this study focused on the roles of stabilizers (hydroxypropyl cellulose and sodium lauryl sulfate) and elucidation of the so-called Rehbinder effect (reduction in particle strength due to adsorbed stabilizers such as polymers and surfactants). Milling the drugs in the absence of the stabilizers produced primary nanoparticles and their aggregates, while milling with the stabilizers produced smaller primary nanoparticles with minimal aggregation. Using laser diffraction, BET nitrogen adsorption, scanning electron microscopy imaging, and a microhydrodynamic analysis of milling, this study, for the first time, provides sufficient evidence for the existence of the Rehbinder effect during the milling of drugs. Not only do the polymers and surfactants allow proper stabilization of the nanoparticles in the suspensions, but they also do facilitate drug particle breakage.

摘要

BCS 类 II 药物的纳米颗粒是在湿搅拌介质磨机中生产的,该磨机以批处理或再循环模式运行,目的是解决水溶解度差的问题。关于通过湿介质研磨连续生产药物纳米颗粒的信息很少。灰黄霉素和萘普生在再循环模式和多通道连续模式下进行研磨,以研究破碎动力学并确定悬浮液流速的影响。用经验破碎模型测量和描述中值粒径的演变。我们发现这两种操作模式可以生产出具有相似粒径分布 (PSD) 的药物纳米混悬剂。降低悬浮液流速会降低破碎速率,并导致 PSD 变宽,两种操作模式之间的差异更大。本研究的后半部分重点研究稳定剂(羟丙基纤维素和十二烷基硫酸钠)的作用,并阐明所谓的 Rehbinder 效应(由于聚合物和表面活性剂等吸附稳定剂导致的颗粒强度降低)。在没有稳定剂的情况下研磨药物会产生初级纳米颗粒及其聚集体,而使用稳定剂研磨则会产生更小的初级纳米颗粒,且聚集体最小。通过激光衍射、BET 氮气吸附、扫描电子显微镜成像和微流动力学分析,本研究首次提供了充分的证据,证明在药物研磨过程中存在 Rehbinder 效应。聚合物和表面活性剂不仅允许在悬浮液中适当稳定纳米颗粒,而且还促进药物颗粒破碎。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验